Latest News
CrowdStrike Slips 5.3% Ahead of Earnings; Options Signal 10% Move
CrowdStrike shares dropped 5.3% to $201.58 ahead of its Aug 26 earnings, with options pricing a 10% move. The decline is a pre-earnings de-risking, not a post-results verdict.
Hyperliquid Strategies Soars 23% on US Compliance Hopes
Hyperliquid Strategies (PURR) surged 23% after Trump indicated a US compliance path for HYPE, with shares hitting $8.88 and trading volume 3.3x average.
MRK Surges 13% on Cancer Vaccine Data, Market Cap Jumps $44B
Merck (MRK) shares soared 13.3% to $153.12 after promising Phase 3 data for its melanoma vaccine with Moderna (MRNA), boosting market cap by $44.4B.
Samsung Foundry Price Hike Highlights AI Chip Capacity Crunch
Samsung's foundry price hike of up to 15% signals tight AI chip capacity. TSMC shares remain flat despite strong July revenue growth of 44.7%.
Eli Lilly Stock Near Record as Volume Surge Offsets Price Cuts
Eli Lilly (LLY) nears all-time high as Q2 volume surges 60%, offsetting a 13% price drop. Mounjaro and Zepbound account for 64% of revenue.
Fed Minutes Signal More Hikes, but Treasury Buybacks Mute Long-End Reaction
Fed minutes show wider backing for a July hike, but Treasury buybacks keep long yields in check. Two-year yield barely moves while 30-year falls.
Loonie Hits 2½-Month Peak; Tariff Truce Leaves Risk Skewed
The Canadian dollar climbed to its strongest level since June 2, buoyed by a temporary U.S. tariff suspension, yet a 1.4-to-1 downside risk skew persists as trade talks remain uncertain.
CXMT's $586B Valuation Hinges on Tiny 6.7% Float
CXMT's $586B market cap is supported by only 6.7% tradable shares, amplifying volatility. The stock fell 2.77% to ¥57.55, but remains up 7.5% since Aug. 12.
